These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23329761)

  • 1. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
    Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women.
    Song JF; Jing ZZ; Hu W; Su YX
    Genet Mol Res; 2013 Sep; 12(3):3279-85. PubMed ID: 24065669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women.
    Wang Q; Chen Z; Huang Y; Li Q; Zhu L; Cai X; He G; Xie Y; Liu Q
    Int Immunopharmacol; 2013 Oct; 17(2):404-7. PubMed ID: 23856613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
    Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
    Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
    García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
    Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].
    Wang C; He JW; Qin YJ; Zhang H; Hu WW; Liu YJ; Zhang ZL
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2958-62. PubMed ID: 20137703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of osteoprotegerin genetic polymorphisms on bone mineral density and osteoporosis in Chinese postmenopausal women.
    Sun T; Chen M; Lin X; Yu R; Zhao Y; Wang J
    Int Immunopharmacol; 2014 Sep; 22(1):200-3. PubMed ID: 24975835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
    Mencej-Bedrač S; Preželj J; Marc J
    Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between osteoprotegerin genetic variants and osteoporosis in Chinese postmenopausal women.
    Yu F; Huang X; Miao J; Guo L; Tao D
    Endocr J; 2013; 60(12):1303-7. PubMed ID: 24067544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women.
    Zhang F; He C; Chen G; Li F; Gao H
    Med Oncol; 2013 Mar; 30(1):389. PubMed ID: 23335067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women.
    Rojano-Mejía D; Coral-Vázquez RM; Espinosa LC; Romero-Hidalgo S; López-Medina G; García Mdel C; Coronel A; Ibarra R; Canto P
    Maturitas; 2012 Jan; 71(1):49-54. PubMed ID: 22079369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the impact of candidate genes on bone mineral density in postmenopausal women].
    Zhao HY; Liu JM; Ning G; Zhang LZ; Song HD; Chen Y; Jiang L; Dai M; Xu MY; Chen JL
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):803-7. PubMed ID: 16412323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].
    Cheng Q; Zhu HM; Miao YX; Zhu XY; Chen XP; Zhang XM
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):274-7. PubMed ID: 15059506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women.
    Liu S; Yi Z; Ling M; Shi J
    Hormones (Athens); 2013; 12(4):578-83. PubMed ID: 24457406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis.
    Peng Y; Sheng X; Xue F; Qian Y
    Medicine (Baltimore); 2018 Dec; 97(51):e13507. PubMed ID: 30572450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
    Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
    Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
    Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
    J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.
    Vidal C; Brincat M; Xuereb Anastasi A
    Maturitas; 2006 Mar; 53(4):386-95. PubMed ID: 16343827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women.
    Markatseli AE; Hatzi E; Bouba I; Georgiou I; Challa A; Tigas S; Tsatsoulis A
    Maturitas; 2011 Oct; 70(2):188-93. PubMed ID: 21840657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.